Sort
82,697 grants matching “vaccine development”
Integrated polymer microfluidic device for multiplex diagnosis of viral infection
$823,047Robert G. Ulrich · Geneva Foundation · R01 · FY2012 · AI
Immunogen Design and Selection
$822,960Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2014 · AI
Innate Immunity Stimulation Effects on Biomarkers, Cognition, and the Vascular Amyloid Proteome in a Squirrel Monkey Model of Sporadic CAA
$822,959Henrieta Scholtzova · New York University School Of Medicine · R01 · FY2023 · NS
Prenatal Factors and Risk of Schizophrenia in a Finnish National Birth Cohort
$822,929Alan Stewart Brown · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2011 · MH
Biomarker Investigations for Clinical Trials
$822,832Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Impact of the COVID-19 Pandemic on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias
$822,779John Hsu · Massachusetts General Hospital · U01 · FY2023 · AG
Tracking the evolutionary trajectory of neutralizing antibodies following BG505 SOSIP immunization
$822,777Cynthia Ann Derdeyn · University Of Washington · R01 · FY2023 · AI
Development of Influenza Virus-Like Particle (VLP) Vaccines
$822,755Jose M Galarza · Technovax, Inc. · R44 · FY2009 · AI
Systems Biology Core
$822,747Alan A Aderem · Scripps Research Institute, The · U19 · FY2012 · AI
Collaborative Research: Ideas Lab: The Role of Extracellular RNA in Intercellular and Interkingdom Communication
$822,736Miriam K Konkel · Clemson University · · FY2023 · BIO
Development of New Bivalent Cross-Protective Arenaviral Vaccines
$822,732Igor S. Lukashevich · University Of Louisville · R01 · FY2012 · AI
Physical Resources Core
$822,707Justin Joseph Pollara · Duke University · P01 · FY2022 · AI
Functional Biology Of T Cells
$822,686Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Structural insights into pandemic and emerging influenza viruses
$822,570Ian A Wilson · Scripps Research Institute, The · R56 · FY2013 · AI
Development of a pre-erythrocytic P. vivax vaccine to prevent clinical relapse
$822,542D. Noah Sather · Seattle Children'S Hospital · R01 · FY2020 · AI
Development of a pre-erythrocytic P. vivax vaccine to prevent clinical relapse
$822,542D. Noah Sather · Seattle Children'S Hospital · R01 · FY2021 · AI
Development of a pre-erythrocytic P. vivax vaccine to prevent clinical relapse
$822,542D. Noah Sather · Seattle Children'S Hospital · R01 · FY2022 · AI
Development of a pre-erythrocytic P. vivax vaccine to prevent clinical relapse
$822,542D. Noah Sather · Seattle Children'S Hospital · R01 · FY2023 · AI
Dissecting Hepatitis B Vaccine Adjuvant Effects on Immune Responses and the HIV Reservoir in PLWH
$822,489Andrea L Cox · Johns Hopkins University · R01 · FY2025 · AI
Cooperative Research Partnership for an Amebic Colitis Vaccine
$822,444William A Petri · University Of Virginia · U01 · FY2010 · AI
Identifying and modeling immune correlates of protection against congenital CMV transmission after primary maternal infection
$822,260Sallie R. Permar · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Infant Immunoprophylaxis against a Primate Lentivirus
$822,250Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · R37 · FY2009 · AI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection
$822,232Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2018 · AI
Molecular Genetic Basis of the Infectious Cycle of Borrelia burgdorferi
$822,202Patricia A Rosa · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Structure and Dynamics of the SARS-CoV-2 Spike Protein
$822,106Walther H Mothes · Yale University · R01 · FY2024 · AI